Robert Alcala has extensive experience in the pharmaceutical and biotechnology sectors, specializing in rare diseases, immunology, and hematology. Key roles include serving as Responsable Scientifique Régional Maladies Rares at LFB from March 2012 to August 2019, and currently holding the position of Senior Medical Science Liaison for Immunology Dermatology Pipeline at AbbVie since January 2022. Previous positions include responsibilities at Pfizer, CSL, Takeda, and Sanofi Pasteur MSD, where Robert Alcala focused on medical information management, therapeutic education, and clinical development. Educationally, Robert Alcala holds an engineering degree in Industrial and Applied Biotechnologies from Ecole Polytechnique Universitaire de Marseille and a university diploma in Microangiopathies and other immune diseases from Université Paris-Sorbonne.
This person is not in the org chart
This person is not in any teams
This person is not in any offices